Respiratory Syncytial Virus Bronchiolitis and Risk of Subsequent Wheezing: A Matter of Severity-Reference-Cited by-同舟云学术

Respiratory Syncytial Virus Bronchiolitis and Risk of Subsequent Wheezing: A Matter of Severity

Published:2006-03 Issue:1 Volume:19 Page:26-30
ISSN:0883-1874
Container-title:Pediatric Asthma, Allergy & Immunology
language:en
Short-container-title:Pediatric Asthma, Allergy & Immunology

Author:

Al-Shawwa Baha,Al-Huniti Nidal,Abu-Hasan Mutasim

Publisher

Mary Ann Liebert Inc

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health,Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Reference21 articles.

1. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy.

2. Respiratory status and allergy after bronchiolitis.

3. Wheezing requiring hospitalization in early childhood: Predictive factors for asthma in a six-year follow-up

4. RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life

5. Viral infections, atopy, and asthmaIs there a causal relationship?

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time-Varying Association Between Severe Respiratory Syncytial Virus Infections and Subsequent Severe Asthma and Wheeze and Influences of Age at the Infection;The Journal of Infectious Diseases;2021-09-15

2. Risk of asthma in children diagnosed with bronchiolitis during infancy: protocol of a longitudinal cohort study linking emergency department-based clinical data to provincial health administrative databases;BMJ Open;2021-05

3. Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting;Vaccine;2020-03

4. Factors Associated With Asthma Diagnosis Within Five Years of a Bronchiolitis Hospitalization: A Retrospective Cohort Study in a High Asthma Prevalence Population;Hospital Pediatrics;2019-10-01

5. Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain;BMC Infectious Diseases;2017-10-17